STEPHANIE BELLO: Open Payments
NPI 1518727684 · PENSACOLA, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,755 in 72 payments from 16 companies in 2025. Trend: 2023 $0 · 2024 $1,368 · 2025 $1,755
Food & beverage: $1,755
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 12 | $474 |
| Novo Nordisk Inc | 12 | $256 |
| GlaxoSmithKline, LLC. | 6 | $183 |
| Lilly USA, LLC | 15 | $173 |
| Insulet Corporation | 1 | $114 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $100 |
| Astellas Pharma US Inc | 4 | $89 |
| Exact Sciences Corporation | 4 | $89 |
| ABBVIE INC. | 2 | $62 |
| Sumitomo Pharma America, Inc. | 3 | $60 |
Products named: FARXIGA, AIRSUPRA, Wegovy, SHINGRIX, OMNIPOD, TRINTELLIX, MOUNJARO, Veozah.
Industry payments across FL — which companies pay providers there.
